Somatic Systems Net Income
| SMAS Stock | USD 0.0001 0.00 0.00% |
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Somatic Systems, as well as the relationship between them.
Somatic Systems Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -215.2 K | -225.9 K | |
| Net Loss | -215.2 K | -225.9 K | |
| Net Loss | -215.2 K | -225.9 K |
Somatic | Net Income | Build AI portfolio with Somatic Stock |
The evolution of Net Income for Somatic Systems provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Somatic Systems compares to historical norms and industry peers.
Latest Somatic Systems' Net Income Growth Pattern
Below is the plot of the Net Income of Somatic Systems over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Somatic Systems financial statement analysis. It represents the amount of money remaining after all of Somatic Systems operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Somatic Systems' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Somatic Systems' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (239.08 K) | 10 Years Trend |
|
Net Income |
| Timeline |
Somatic Net Income Regression Statistics
| Arithmetic Mean | (231,299) | |
| Coefficient Of Variation | (10.13) | |
| Mean Deviation | 12,818 | |
| Median | (239,081) | |
| Standard Deviation | 23,433 | |
| Sample Variance | 549.1M | |
| Range | 95.2K | |
| R-Value | (0.26) | |
| Mean Square Error | 546.6M | |
| R-Squared | 0.07 | |
| Significance | 0.32 | |
| Slope | (1,199) | |
| Total Sum of Squares | 8.8B |
Somatic Net Income History
Other Fundumenentals of Somatic Systems
Somatic Systems Net Income component correlations
Click cells to compare fundamentals
Is there potential for Personal Services market expansion? Will Somatic introduce new products? Factors like these will boost the valuation of Somatic Systems. If investors know Somatic will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Somatic Systems listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Somatic Systems is measured differently than its book value, which is the value of Somatic that is recorded on the company's balance sheet. Investors also form their own opinion of Somatic Systems' value that differs from its market value or its book value, called intrinsic value, which is Somatic Systems' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Somatic Systems' market value can be influenced by many factors that don't directly affect Somatic Systems' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Somatic Systems' value and its price as these two are different measures arrived at by different means. Investors typically determine if Somatic Systems is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Somatic Systems' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Somatic Systems 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Somatic Systems' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Somatic Systems.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Somatic Systems on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Somatic Systems or generate 0.0% return on investment in Somatic Systems over 90 days. Somatic Systems is related to or competes with Medigene, and Mid-Atlantic Home. Somatic Systems, Inc. provides drug-free and non-surgical approach to movement disorders, musculoskeletal problems, and ... More
Somatic Systems Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Somatic Systems' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Somatic Systems upside and downside potential and time the market with a certain degree of confidence.
Somatic Systems Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Somatic Systems' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Somatic Systems' standard deviation. In reality, there are many statistical measures that can use Somatic Systems historical prices to predict the future Somatic Systems' volatility.Somatic Systems Backtested Returns
We have found three technical indicators for Somatic Systems, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Somatic Systems are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Somatic Systems has perfect predictability. Overlapping area represents the amount of predictability between Somatic Systems time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Somatic Systems price movement. The serial correlation of 1.0 indicates that 100.0% of current Somatic Systems price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Somatic Operating Income
Operating Income |
|
Based on the recorded statements, Somatic Systems reported net income of (239,081). This is 100.05% lower than that of the Consumer Cyclical sector and 100.1% lower than that of the Personal Services industry. The net income for all United States stocks is 100.04% higher than that of the company.
Somatic Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Somatic Systems' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Somatic Systems could also be used in its relative valuation, which is a method of valuing Somatic Systems by comparing valuation metrics of similar companies.Somatic Systems is currently under evaluation in net income category among its peers.
Somatic Fundamentals
| Profit Margin | (2.23) % | ||||
| Operating Margin | (4.97) % | ||||
| Current Valuation | 1.46 M | ||||
| Shares Outstanding | 14.6 B | ||||
| Price To Sales | 13.59 X | ||||
| Revenue | 107.42 K | ||||
| Gross Profit | 97.66 K | ||||
| EBITDA | (215.35 K) | ||||
| Net Income | (239.08 K) | ||||
| Cash And Equivalents | 7.67 K | ||||
| Total Debt | 353.61 K | ||||
| Current Ratio | 0.39 X | ||||
| Cash Flow From Operations | (199.9 K) | ||||
| Beta | -272.3 | ||||
| Market Capitalization | 1.46 M | ||||
| Total Asset | 189.28 K | ||||
| Retained Earnings | (1.16 M) | ||||
| Net Asset | 189.28 K |
About Somatic Systems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Somatic Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Somatic Systems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Somatic Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Somatic Stock Analysis
When running Somatic Systems' price analysis, check to measure Somatic Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Somatic Systems is operating at the current time. Most of Somatic Systems' value examination focuses on studying past and present price action to predict the probability of Somatic Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Somatic Systems' price. Additionally, you may evaluate how the addition of Somatic Systems to your portfolios can decrease your overall portfolio volatility.